Pharmaceutical manufacturing

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial results Tuesday, April 30, 2019. (AP Photo/Seth Wenig, File)
April 30, 2019 - 7:23 am
KENILWORTH, N.J. (AP) — Merck is breezing past all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion. The New Jersey drugmaker on Tuesday said it earned $2.92 billion, or $1.12 per share. Earnings, adjusted for one-time gains and costs, were $1.22 per...
Read More
FILE- In this March 18, 2019, file photo specialist Meric Greenbaum, left, and trader Fred DeMarco work on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EDT on Monday, April 29. (AP Photo/Richard Drew, File)
April 29, 2019 - 10:24 am
NEW YORK (AP) — U.S. stocks followed a record-setting week by edging slightly higher in early trading on Wall Street Monday. Solid corporate earnings reports helped take some pressure off the market over the last several weeks. Analysts have been expecting a sharp downturn in corporate profit, but...
Read More
Chelsea Lydell holds her son, Joseph, 4, as she joins hundreds of others waiting to get into a legislative committee to oppose a proposal to give state public health officials instead of local doctors the power to decide which children can skip their shots before attending school, at the Capitol Wednesday, April 24, 2019, in Sacramento, Calif. The bill, by state Sen. Richard Pan, D-Sacramento, a pediatrician, said his legislation would give state health officials the tools they need to prevent outbreaks of vaccine-preventable diseases like measles. (AP Photo/Rich Pedroncelli)
April 24, 2019 - 11:27 pm
SACRAMENTO, Calif. (AP) — California lawmakers advanced tougher rules for vaccinations late Wednesday after hearing hours of testimony from hundreds of opponents while the nation grapples with the highest number of measles cases in decades. The Senate Health Committee approved the proposal to give...
Read More
FILE - In this Oct. 30, 2009 file photo, a mother holds her baby receiving a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya. The World Health Organization said Tuesday April 23, 2019, that Malawi has become the first country to introduce a pilot program vaccinating children against malaria using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one third of children who are immunized, those who get the shot are likely to have less severe cases of malaria. (AP Photo/Karel Prinsloo, File)
April 23, 2019 - 3:52 pm
LONDON (AP) — The World Health Organization says Malawi has become the first country to begin immunizing children against malaria, using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one-third of children who are immunized, those...
Read More
FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara. The New Brunswick, N.J., company on Tuesday, April 16, 2019 posted profit of $3.75 billion, or $1.39 per share. Earnings, adjusted for amortization costs and research and development costs, were $2.10 per share, or 7 cents better that Wall Street expected, according to a survey by Zacks Investment Research. (AP Photo/Matt Rourke, File)
April 16, 2019 - 8:41 am
Lower sales overseas and higher costs for research and litigation pushed Johnson & Johnson's first-quarter profit down 14%. Still, the health care giant beat profit and revenue expectations, pushing up its shares in premarket trading. The maker of Tylenol and psoriasis drug Stelara on Tuesday...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More
April 03, 2019 - 5:50 pm
LITTLE ROCK, Ark. (AP) — Arkansas lawmakers have sent the governor legislation expanding the secrecy surrounding the source of the state's lethal injection drugs, over the objections of press groups, pharmaceutical companies and death penalty opponents. The House voted 71-16 on Wednesday for a bill...
Read More
Vaccine
Dreamstime
March 22, 2019 - 7:42 am
WALTON, Ky. (AP) — An unvaccinated student in Kentucky will get his day in court after suing because he can't participate in extracurricular activities during a chickenpox outbreak. The Courier Journal reports 18-year-old Jerome Kunkel's case will be heard in court April 1. Unvaccinated students...
Read More
March 19, 2019 - 7:06 pm
TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics' Zulresso, an IV drug given over 2 ½ days. Sage said Zulresso will cost $34,000 without insurance,...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 9:54 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad warns that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of the Alliance for Patient Access, a...
Read More

Pages